Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SPRY

ARS Pharmaceuticals Inc

May 08 • 04:00PM ET

8.74

-0.26 -2.89 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT ARQT TRVI CABA AUPH

| Held by: XBI VTI IWM VXF IWO IBB SCHA VTWO SMLF VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.74	Insider Own	36.94%	Shs Outstand	99.29M	Perf Week	2.10%
Market Cap	867.86M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-0.51%	Shs Float	62.62M	Perf Month	5.68%
Enterprise Value	719.83M	PEG	-	EPS next Q	-0.52	Inst Own	73.11%	Short Float	42.74%	Perf Quarter	-12.86%
Income	-171.30M	P/S	10.30	EPS this Y	9.20%	Inst Trans	0.95%	Short Ratio	18.36	Perf Half Y	-3.43%
Sales	84.28M	P/B	7.60	EPS next Y	52.03%	ROA	-50.47%	Short Interest	26.76M	Perf YTD	-24.98%
Book/sh	1.15	P/C	3.54	EPS next 5Y	-	ROE	-92.33%	52W High	18.90 -53.76%	Perf Year	-35.21%
Cash/sh	2.47	P/FCF	-	EPS past 3/5Y	-26.04% -12.85%	ROIC	-81.33%	52W Low	6.66 31.23%	Perf 3Y	45.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	300.09% -	Gross Margin	75.77%	Volatility	5.62% 5.26%	Perf 5Y	-68.96%
Dividend TTM	-	EV/Sales	8.54	EPS Y/Y TTM	-2365.06%	Oper. Margin	-212.92%	ATR (14)	0.48	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.06	Sales Y/Y TTM	-5.46%	Profit Margin	-203.25%	RSI (14)	54.83	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.28	EPS Q/Q	-181.84%	SMA20	4.70%	Beta	0.92	Target Price	26.20
Payout	-	Debt/Eq	0.85	Sales Q/Q	-67.56%	SMA50	4.10%	Rel Volume	0.87	Prev Close	9.00
Employees	163	LT Debt/Eq	0.84	Earnings	May 15 BMO	SMA200	-15.55%	Avg Volume	1.46M	Price	8.74
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.63% 9.69%	Trades		Volume	1,271,954	Change	-2.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)